Catalent partnered with Humanigen to support FDA approved phase 3 lenzilumab study for COVID-19
On May 7, 2020, Catalent announced Phase 3 study for lenzilumab, the companyメs proprietary Humaneeredᆴ anti-human granulocyte macrophage-colony…
On May 7, 2020, Catalent announced Phase 3 study for lenzilumab, the companyメs proprietary Humaneeredᆴ anti-human granulocyte macrophage-colony…
On May 7, 2020, Tonix Pharmaceuticals and the University of Alberta announced a research collaboration and exclusive licensing…
On May 7, 2020, a study of nearly 1,400 patients with moderate to severe COVID-19 disease at a…
On May 7, 2020, the CoVId-19 Plasma Alliance, an unprecedented plasma industry collaboration recently established to accelerate the…
On May 6, 2020, Baxter announced results of the Fluid Response Evaluation in Sepsis Hypotension and Shock (FRESH)…
On May 6, 2020, Mesoblast announced that the first patients were dosed in the 300-patient randomized placebo-controlled Phase…
On May 6, 2020, the U.S. Dept. of Agriculture (USDA) announced that a new freeze-resistant Trichinella species had…
On May 6, 2020, Sinovac Biotech announced publication of the preclinical study on animals for its vaccine candidate…
On May 6, 2020, IGEA Pharma announced that an evaluation by the University of Miami Miller School of…
On May 6, 2020, bioMerieux announced performance validation and the launch of VIDAS anti-SARS-CoV-2 serology tests to detect…
On May 6, 2020, Laurent Pharmaceuticals announced that it has obtained the approval from Health Canada to initiate…
On May 6, 2020, PharmaCyte Biotech announced it had received Medical Devices Establishment Registration with the FDAメs Center…
On May 6, 2020, Humanigen announced that the first COVID-19 patient had been dosed in its previously announced…
On May 6, 2020, 3M and Ford announced that newly designed powered air-purifying respirators (PAPRs), developed are on…
On May 6, 2020, Predictive Oncology announced the acquisition of Soluble Therapeutics and partnership and licensing of a…
On May 6, 2020, Meridian Bioscience announced a collaboration with QuantuMDx on its newly launched SARS-CoV-2 assay for…
On May 6, 2020, the U.S. Food and Drug Administration (FDA) approved Tabrecta (capmatinib) for the treatment of…
On May 5, 2020, the U.S. Dept. of Veterans Affairs (VA) announced the Airborne Hazards and Open Burn…
On May 5, 2020, PerkinElmer announced the FDA provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company)…
On May 5, 2020, Medigen Vaccine Biologics (MVB) announced a global commercial license agreement with National Institutes of…
On May 5, 2020, the HonorHealth Research Institute and HonorHealth announced the successful enrollment on a novel combination…
On May 6, 2020, Lineage Cell Therapeutics announced that it has applied for grant funding from the California…
On May 6, 2020, ResMed launched cloud-based remote monitoring software for ventilators and Lumis bilevel devices across Europe,…
On May 5, 2020, Organicell Regenerative Medicine announced the FDA has approved the Investigational New Drug application for…
On May 5, 2020, Tyson Foods announced resumption of limited production at its Waterloo, Iowa facility May 7….
On May 5, 2020, Innovation Pharma reported it had executed a Material Transfer Agreement (MTA) with a leading…
On May 5, 2020, Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham,…
On May 5, 2020, a team of researchers at the McGovern Institute for Brain Research at MIT, the…
On May 5, 2020, LabCorp announced that its COVID-19 Immunoglobulin G (IgG) antibody test is now available for…
On May 5, 2020, Pfizer and BioNTech announced the first participants have been dosed in the U.S. in…